Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 3 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for AN2 Therapeutics Inc have a median target of 5.00, with a high estimate of 25.00 and a low estimate of 1.00. The median estimate represents a 362.96% increase from the last price of 1.08.
High | 2,214.8% | 25.00 |
Med | 363.0% | 5.00 |
Low | -7.4% | 1.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | +12.03% |
Average growth rate | +1.79% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼